MARKET

BFRI

BFRI

Biofrontera Inc
NASDAQ
0.7789
-0.0401
-4.90%
Pre Market: 0.7900 +0.0111 +1.43% 08:40 03/31 EDT
OPEN
0.8189
PREV CLOSE
0.8190
HIGH
0.8190
LOW
0.7660
VOLUME
280
TURNOVER
0
52 WEEK HIGH
1.190
52 WEEK LOW
0.5360
MARKET CAP
9.07M
P/E (TTM)
-0.7520
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BFRI last week (0323-0327)?
Weekly Report · 1d ago
Weekly Report: what happened at BFRI last week (0316-0320)?
Weekly Report · 03/23 10:37
Roth MKM Reaffirms Their Buy Rating on Biofrontera (BFRI)
TipRanks · 03/20 13:17
Biofrontera Earnings Call: Profits Rise, Risks Remain
TipRanks · 03/20 00:09
Biofrontera Q4 EPS $0.48 Beats $0.20 Estimate, Sales $17.100M Beat $16.146M Estimate
Benzinga · 03/19 21:49
Biofrontera reports rise in Q4 revenue, turns profitable
Seeking Alpha · 03/19 19:18
Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition
Seeking Alpha · 03/19 19:12
Dermatology drugmaker Biofrontera's Q4 revenue rises to record high on Ameluz strength
Reuters · 03/19 13:36
More
About BFRI
Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Webull offers Biofrontera Inc stock information, including NASDAQ: BFRI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRI stock methods without spending real money on the virtual paper trading platform.